Baxter International Inc. (BAX)

Who Is Baxter International?

If you have ever been on an IV drip in a US hospital, there is a good chance you used a Baxter product without realizing it. Baxter International (NYSE: BAX) is one of the most ubiquitous suppliers of basic hospital infrastructure in the world - IV (intravenous) fluids, infusion pump systems, injectable products (drug compounding), advanced surgery equipment, and patient monitoring / front line care systems. Nearly every major US hospital bed has a Baxter product somewhere in the room.

A Difficult Decade

But Baxter's story over the past three years has been far from pretty. The company went through a major breakup - selling BioPharma Solutions (2023) and its entire Vantive Kidney Care segment to Carlyle in January 2025 for ~$3.8 billion cash. The dividend that was once a point of pride (dividend-aristocrat-type identity) was slashed a brutal 94% - from $0.17/quarter down to just $0.01/quarter, effective the January 2026 payment. To make matters worse, in February 2026 the company issued 2026 guidance well below Wall Street's expectations - the stock crashed 16% in a single day.

The First Sign of Recovery

After all that drama, the first genuine sign of a turnaround has finally appeared. Andrew Hider, former CEO of ATS Corporation (an industrial automation company), was appointed Baxter's CEO effective September 2025 - an operations-focused industrialist, not a traditional pharma executive. On 30 July 2026, Baxter reported Q2 2026 results that crushed expectations (adjusted EPS $0.56 vs $0.37 expected) and raised full-year guidance. The stock jumped roughly 17% in a single day - from $24.77 to an intraday high near $29, before settling around $26.81.

Shariah Status

Important for Shariah-conscious investors: Baxter International is NON-COMPLIANT (Shariah) in our database. This is not a candidate for Shariah-compliant portfolios - the stock is only suitable for conventional investors comfortable with that classification.

This section is being refreshed with the latest figures. Please check back soon.

This section is being refreshed with the latest figures. Please check back soon.